Literature DB >> 18651036

Cardiovascular disorders in patients with diabetes mellitus.

Nobuakira Takeda1, Chihiro Shikata, Tetsuaki Sekikawa, Nobuaki Kimura, Akihiro Nishiyama.   

Abstract

Diabetes mellitus is a disease with multiorgan involvement. Besides retinopathy, nephropathy and peripheral neuropathy induced by microangiopathy, both cardiovascular and cerebrovascular complications are significant. Both cardiomyopathy and coronary artery disease are observed in patients with diabetes, and the latter is clinically more important because of its high incidence and seriousness.

Entities:  

Keywords:  Diabetes mellitus; Diabetic cardiomyopathy; Hypertension; Ischemic heart disease

Year:  2006        PMID： 18651036      PMCID： PMC2276153     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN： 1205-6626


  22 in total

1.  Evidence for cardiomyopathy in familial diabetes mellitus.

Authors:  T J Regan; M M Lyons; S S Ahmed; G E Levinson; H A Oldewurtel; M R Ahmad; B Haider
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

Review 2.  Subcellular remodeling and heart dysfunction in chronic diabetes.

Authors:  N S Dhalla; X Liu; V Panagia; N Takeda
Journal:  Cardiovasc Res       Date:  1998-11       Impact factor: 10.787

3.  Diabetic cardiomyopathy.

Authors:  R I Hamby; S Zoneraich; L Sherman
Journal:  JAMA       Date:  1974-09-23       Impact factor: 56.272

4.  Diabetes mellitus induces changes in cardiac myosin of the rat.

Authors:  W H Dillmann
Journal:  Diabetes       Date:  1980-07       Impact factor: 9.461

5.  Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes.

Authors:  G N Pierce; M J Kutryk; N S Dhalla
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

6.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

7.  2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

Authors: 
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

8.  Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats.

Authors:  N Makino; K S Dhalla; V Elimban; N S Dhalla
Journal:  Am J Physiol       Date:  1987-08

9.  Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Authors:  K Pyŏrälä; T R Pedersen; J Kjekshus; O Faergeman; A G Olsson; G Thorgeirsson
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

10.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.